Three Sirna Shareholders Sue to Block Merck Acquisition; Sirna Posts Higher Q3 Losses

/Home/Biologics Delivery - Protein Synthesis/RNA - Protein Synthesis/RNAi - Protein Synthesis

Three Sirna Shareholders Sue to Block Merck Acquisition; Sirna Posts Higher Q3 Losses
By Doug Macron
November 16, 2006
RNAi News
Sirna said the lawsuits, which are seeking class-action status, accuse CEO Robin and seven directors of violating fiduciary responsibility by seeking personal enrichment at the expense of ordinary shareholders.
Paid subscription is required to view article.